Associated Papers
Genetic Associations of TCF7L2 (rs7903146) and PPARG (rs1801282) with Prediabetes in the Ethnic Kazakh Population.
Dyussupova A et al.
Diagnostics (basel, Switzerland), 2024
Putative protective genomic variation in the Lithuanian population.
Žukauskaitė G et al.
Genetics and Molecular Biology, 2024
Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features.
Soares RMV et al.
Frontiers in Endocrinology, 2024
Decoding type 2 diabetes mellitus genetic risk variants in Pakistani Pashtun ethnic population using the nascent whole exome sequencing and MassARRAY genotyping: A case-control association study.
Jan A et al.
Plos One, 2023
Variable Expressivity and Allelic Heterogeneity in Type 2 Familial Partial Lipodystrophy: The p.(Thr528Met) LMNA Variant.
Araújo-Vilar D et al.
Journal of Clinical Medicine, 2021
Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population.
Gong S et al.
Frontiers in Endocrinology, 2021
PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis.
Ding H et al.
Oncotarget, 2017
Allele-specific quantitative proteomics unravels molecular mechanisms modulated by cis-regulatory PPARG locus variation.
Lee H et al.
Nucleic Acids Research, 2017
Prospective functional classification of all possible missense variants in PPARG.
Majithia AR et al.
Nature Genetics, 2016
Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa.
Vergotine Z et al.
Bmc Genetics, 2014
Variants in ABCB1, TGFB1, and XRCC1 genes and susceptibility to viral hepatitis A infection in Mexican Americans.
Zhang L et al.
Hepatology (baltimore, Md.), 2012
The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course.
Mwinyi J et al.
Ppar Research, 2012
Evolution of peroxisome proliferator-activated receptor gamma alternative splicing.
Dou T et al.
Frontiers in Bioscience (elite Edition), 2010
PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor.
Sanghera DK et al.
Metabolism: Clinical and Experimental, 2010
Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm.
Moran CS et al.
Clinical Endocrinology, 2010
Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.
Breyer JP et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2009
Marker selection for genetic case-control association studies.
Pettersson FH et al.
Nature Protocols, 2009
Impact of the Pro12Ala polymorphism of the PPAR-Gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients.
Ereqat S et al.
Ppar Research, 2009
Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study.
Lagou V et al.
Obesity (silver Spring, Md.), 2008
Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study.
Golledge J et al.
Human Genetics, 2008
In vitro effect of PPAR-gamma2 Pro12Ala polymorphism on the deposition of Alzheimer's amyloid-beta peptides.
d'Abramo C et al.
Brain Research, 2007
Investigation of the Lith6 candidate genes APOBEC1 and PPARG in human gallstone disease.
Schafmayer C et al.
Liver International : Official Journal of the International Association for the Study of the Liver, 2007
Human non-synonymous single nucleotide polymorphisms can influence ubiquitin-mediated protein degradation.
Savas S et al.
Omics : a Journal of Integrative Biology, 2007